InvestSMART

Entropy Neurodynamics Limited (ASX: ENP) - Announcements

Current share price for ENP : $0.031 0.001 (3.33%)+

ASX company news and announcements for Entropy Neurodynamics Limited (ENP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Entropy Neurodynamics Limited (ENP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Entropy Neurodynamics Limited (ENP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Entropy Neurodynamics Limited (ENP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$51 Quarterly Activities Report and Appendix 4C 22 Jul 2026 8:26AM $0.034 $0.031 fallen by 8.82%
$51 South Africa Grants ENP Broad Fibromyalgia Patent to 2043 20 Jul 2026 8:35AM $0.036 $0.031 fallen by 13.89%
$51 Additional Australian patent granted 10 Jul 2026 9:07AM $0.034 $0.031 fallen by 8.82%
$51 Investor Presentation 9 Jul 2026 11:13AM $0.034 $0.031 fallen by 8.82%
$51 100% Clinical improvement, 50% Remission in BED study 7 Jul 2026 9:37AM $0.032 $0.031 fallen by 3.13%
$51 Trading Halt 3 Jul 2026 9:09AM $0.032 $0.031 fallen by 3.13%
$51 Application for quotation of securities - ENP 26 Jun 2026 12:29PM $0.031 $0.031 fallen by 0%
$51 Top 20 Option Holders & Distribution Schedule 26 Jun 2026 12:25PM $0.031 $0.031 fallen by 0%
$51 Proposed issue of securities - ENP 25 Jun 2026 5:27PM $0.031 $0.031 fallen by 0%
$51 Short Form Prospectus 25 Jun 2026 5:12PM $0.031 $0.031 fallen by 0%
$51 DSMB Clears TRP 8803 to Advance to Cohort 2 15 Jun 2026 9:55AM $0.031 $0.031 fallen by 0%
$51 Entropy completes Cohort 1 dosing in BED trial 2 Jun 2026 8:56AM $0.032 $0.031 fallen by 3.13%
$51 Application for quotation of securities - ENP 29 May 2026 11:07AM $0.032 $0.031 fallen by 3.13%
$51 Release of Securities from Escrow 22 May 2026 1:32PM $0.037 $0.031 fallen by 16.22%
$51 Notification of cessation of securities - ENP 15 May 2026 1:46PM $0.038 $0.031 fallen by 18.42%
$51 Change of Director's Interest Notice - JC 14 May 2026 9:23AM $0.036 $0.031 fallen by 13.89%
$51 Australian Microcap Investment Conference presentation 11 May 2026 9:44AM $0.037 $0.031 fallen by 15.07%
$51 Entropy files new US patent for IBS program 5 May 2026 9:38AM $0.037 $0.031 fallen by 16.22%
$51 TRP 8802 delivers 75% breakthrough response in IBS 4 May 2026 9:08AM $0.037 $0.031 fallen by 16.22%
$51 Quarterly Activities Report and Appendix 4C 28 Apr 2026 9:29AM $0.035 $0.031 fallen by 10.14%
$51 Change of Director's Interest Notice - CN, DT, JC & HJ 20 Apr 2026 2:53PM $0.030 $0.031 risen by 3.33%
$51 Cleansing Notice 17 Apr 2026 4:45PM $0.028 $0.031 risen by 10.71%
$51 Application for quotation of securities - ENP 17 Apr 2026 4:40PM $0.028 $0.031 risen by 10.71%
$51 Cleansing Notice 14 Apr 2026 10:49AM $0.030 $0.031 risen by 3.33%
$51 Application for quotation of securities - ENP 14 Apr 2026 10:47AM $0.030 $0.031 risen by 3.33%

26 - 50 of 80 results

Page 2 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.